ASX:OCC Orthocell (OCC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Orthocell Stock (ASX:OCC) 30 days 90 days 365 days Advanced Chart Get Orthocell alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume669,530 shsAverage VolumeN/AMarket CapitalizationA$375.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia. Read More Receive OCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthocell and its competitors with MarketBeat's FREE daily newsletter. Email Address OCC Stock News HeadlinesBiocurious: Nerve repair champion Orthocell is taking it slow and steady in the US fast laneJuly 9 at 2:48 AM | msn.comWhich ASX All Ords stock is jumping on record quarter?June 30, 2025 | msn.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.July 9 at 2:00 AM | Brownstone Research (Ad)Guess which ASX All Ords stock is jumping 9% on $1.6b market opportunityJune 26, 2025 | msn.comOrthocell sees 4% jump as Remplir used in first US surgery. But is that low?June 26, 2025 | msn.comHealth Check: On Garfield the Cat Day, the biotech sector purrs with deals and breakthroughsJune 19, 2025 | msn.comOrthocell sets new benchmark in nerve repairJune 19, 2025 | msn.comOrthocell’s Remplir Outperforms Standard Nerve Repair Techniques in New StudyJune 18, 2025 | tipranks.comSee More Headlines OCC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Orthocell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Orthocell investors own include Plug Power (PLUG), Viralytics (VRACY), Genetic Technologies (GTG) and GP Strategies (GPX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustrySteel Works Current SymbolASX:OCC CIKN/A Webwww.orthocell.com.au Phone61 8 9360 2888FaxN/AEmployees340Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$7.18 million Net Margins-111.03% Pretax MarginN/A Return on Equity-214.01% Return on Assets-25.04% Debt Debt-to-Equity Ratio15.22 Current Ratio4.34 Quick Ratio5.07 Sales & Book Value Annual SalesA$5.32 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.41 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares209,580,000Free FloatN/AMarket CapA$375.52 million OptionableNot Optionable Beta1.16 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (ASX:OCC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthocell Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthocell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCC Stock Alerts